Weining Robieson

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 683 citations

Advanced Parkinson, Continuous Intrajejunal Infusion, Neurology +3

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser et al. · Movement Disorders · 2014 · 236 citations · Full text

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

Michael J. Soileau, Jason Aldred, Kumar Budur et al. · The Lancet Neurology · 2022 · 172 citations

Advanced Parkinson, Parkinson Disease, Neurology +3

Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials

Anthony E. Lang, Ramon L. Rodriguez, James T. Boyd et al. · Movement Disorders · 2015 · 101 citations · Full text

Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease

Hubert H. Fernandez, James T. Boyd, Victor S.C. Fung et al. · Movement Disorders · 2018 · 93 citations · Full text